Table 6.
Protective Ratio Comparison
| Compound | Numerator Treatment | Denominator Treatment | Protective Ratio | 95% Confidence Interval | P-value |
|---|---|---|---|---|---|
| Aldicarb | Atropine/Saline | Saline/Saline | 3.3* | (2.86, 3.81) | <0.0001 |
| Saline/2-PAM Cl | Saline/Saline | 1.3 | (1.14, 1.57) | 0.003 | |
| Atropine/2-PAM Cl | Saline/Saline | 2.7* | (1.77, 4.14) | <0.0001 | |
| Atropine/2-PAM Cl | Atropine/Saline | 0.82 | (0.54, 1.25) | 0.3570 | |
| Atropine/2-PAM Cl | Saline/2-PAM Cl | 2.0* | (1.31, 3.13) | 0.0014 | |
| Atropine/Saline | Saline/2-PAM Cl | 2.4* | (2.13, 2.86) | <0.0001 | |
| Methomyl | Atropine/Saline | Saline/Saline | 1.9* | (1.33, 2.67) | 0.0003 |
| Saline/2-PAM Cl | Saline/Saline | 1.1 | (0.99, 1.32) | 0.0683 | |
| Atropine/2-PAM Cl | Saline/Saline | 2.9* | (2.45, 3.29) | <0.0001 | |
| Atropine/2-PAM Cl | Atropine/Saline | 1.5 | (1.05, 2.17) | 0.0251 | |
| Atropine/2-PAM Cl | Saline/2-PAM Cl | 2.5* | (2.08, 2.94) | <0.0001 | |
| Atropine/Saline | Saline/2-PAM Cl | 1.6* | (1.15, 2.38) | 0.0065 |
*
Indicates a significant difference based on the Bonferroni correction, p<0.0083. The Protective ratio is the shift in the MLD between treatment groups.